Calhoun JH, Manring MM, Shirtliff M. Osteomyelitis of the long bones. Semin Plast Surg. 2009;23:59–72.
Rao N, Ziran BH, Lipsky BA. Treating osteomyelitis: antibiotics and surgery. Plast Reconstr Surg. 2011;127:177–87.
Lazzarini L, Mader JT, Calhoun JH. Osteomyelitis in long bones. J Bone Joint Surg Am. 2004;86:2305–18.
Silva GA, Ducheyne P, Reis RL. Materials in particulate form for tissue engineering. 1. Basic concepts. J Tissue Eng Regen Med. 2007;1:4–24.
Xie Z, Liu X, Jia W, Zhang C, Huang W, Wang J. Treatment of osteomyelitis and repair of bone defect by degradable bioactive borate glass releasing vancomycin. J Control Release. 2009;139:118–26.
Causa F, Netti PA, Ambrosio L, Ciapetti G, Baldini N, Pagani S, et al. Poly-epsilon-caprolactone/hydroxyapatite composites for bone regeneration: in vitro characterization and human osteoblast response. J Biomed Mater Res A. 2006;76:151–62.
Kumar TSS, Manjubala I, Gunasekaran J. Synthesis of carbonated calcium phosphate ceramics using microwave irradiation. Biomaterials. 2000;21:1623–9.
Victor SP, Kumar TS. BCP ceramic microspheres as drug delivery carriers: synthesis, characterisation and doxycycline release. J Mater Sci Mater Med. 2008;19:283–90.
Fellah BH, Gauthier O, Weiss P, Chappard D, Layrolle P. Osteogenicity of biphasic calcium phosphate ceramics and bone autograft in a goat model. Biomaterials. 2008;29:1177–88.
Zhu XD, Fan HS, Xiao YM, Li DX, Zhang HJ, Luxbacher T, et al. Effect of surface structure on protein adsorption to biphasic calcium-phosphate ceramics in vitro and in vivo. Acta Biomater. 2009;5:1311–8.
Freier T. Biopolyesters in tissue engineering applications. Adv Polym Sci. 2006;203:1–61.
Mendes JB, Riekes MK, De Oliveira VM, Michel MD, Stulzer HK, Khalil NM, et al. PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes. ScientificWorldJournal. 2012;2012:1–13.
Mehrabanian M, Nasr-Esfahani M. HA/nylon 6,6 porous scaffolds fabricated by salt-leaching/solvent casting technique: effect of nano-sized filler content on scaffold properties. Int J Nanomedicine. 2011;6:1651–9.
Sarasua JR, Lopez-Rodriguez N, Zuza E, Petisco S, Castro B, Del Olmo M, et al. Crystallinity assessment and in vitro cytotoxicity of polylactide scaffolds for biomedical applications. J Mater Sci Mater Med. 2011;22:2513–23.
Cetin D, Kahraman AS, Gümüşderelioğlu M. Novel pHEMA-gelatin SPHs as bone scaffolds in dynamic cultures. J Mater Sci Mater Med. 2012;23:2803–12.
Jiang T, Li Y, Lv Y, Cheng Y, He F, Zhuo R. Biodegradable amphiphilic block-graft copolymers based on methoxy poly(ethylene glycol)-b-(polycarbonates-g-polycarbonates) for controlled release of doxorubicin. J Mater Sci Mater Med. 2013;25:131–9.
Mundargi RC, Srirangarajan S, Agnihotri SA, Patil SA, Ravindra S, Setty SB, et al. Development and evaluation of novel biodegradable microspheres based on poly(d, l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies. J Control Release. 2007;119:59–68.
Wang Q, Wang Q, Wan C. The effect of porosity on the structure and properties of calcium polyphosphate bioceramics. Ceramics. 2011;55:43–8.
Ranjha NM, Ayub G, Naseem S, Ansari MT. Preparation and characterization of hybrid pH-sensitive hydrogels of chitosan-co-acrylic acid for controlled release of verapamil. J Mater Sci Mater Med. 2010;21:2805–16.
Lin SS, Ueng SW, Liu SJ, Chan EC, Chao EK, Tsai CH, et al. Development of a biodegradable antibiotic delivery system. Clin Orthop Relat Res. 1999;362:240–50.
Kankilic B, Bayramli E, Kilic E, Dağdeviren S, Korkusuz F. Vancomycin containing PLLA/beta-TCP controls MRSA in vitro. Clin Orthop Relat Res. 2011;469:3222–8.
Yao Q, Nooeaid P, Roether JA, Dong Y, Zhang Q, Boccaccini AR. Bioglass®-based scaffolds incorporating polycaprolactone and chitosan coatings for controlled vancomycin delivery. Ceram Int. 2013;39:7517–22.
Canut A, Isla A, Betriu C, Gascóm AR. Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries. Eur J Clin Microbiol Infect Dis. 2012;31:2227–35.
Dorozhkin SV. Biocomposites and hybrid biomaterials based on calcium orthophosphates. Biomatter. 2011;1:3–56.
Tang CY, Chen DZ, Yue TM, Chan KC, Tsui CP, Yu PHF. Water absorption and solubility of PHBHV/HA nanocomposites. Compos Sci Technol. 2008;68:1927–34.
Urabe K, Naruse K, Hattori H, Hirano M, Uchida K, Onuma K, et al. In vitro comparison of elution characteristics of vancomycin from calcium phosphate cement and polymethylmethacrylate. J Orthop Sci. 2009;14:784–93.
Rossi S, Azghani AO, Omri A. Antimicrobial efficacy of a new antibiotic-loaded poly(hydroxybutyric-co-hydroxyvaleric acid) controlled release system. J Antimicrob Chemother. 2004;54:1013–8.
International Organization for Standardization. Biological evaluation of medical devices—Part 5: Tests for in vitro cytotoxicity (ISO 10993–5:2009). Geneva: ISO; 2009. p. 1–34.
Ning Z, Xiongbiao C. Biofabrication of tissue scaffolds. In: Pignatello R, editor. Advances in biomaterials science and biomedical applications. Rijeka: InTech; 2013. p. 315–28.
Yang CC, Lin CC, Liao JW, Yen SK. Vancomycin-chitosan composite deposited on post porous hydroxyapatite coated Ti5Al4V implant for drug controlled release. Mater Sci Eng C Mater Biol Appl. 2013;33:2203–12.
Li W, Nooeaid P, Roether JA, Schubert DW, Boccaccini AR. Preparation and characterization of vancomycin releasing PHBV coated 45S5 Bioglass®-based glass-ceramic scaffolds for bone tissue engineering. J Eur Ceram Soc. 2014;34:505–14.
Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.
Soundrapandian C, Datta S, Kundu B, Basu D, Sa B. Porous bioactive glass scaffolds for local drug delivery in osteomyelitis: development and in vitro characterization. AAPS PharmSciTech. 2010;11:1675–83.